Small US company develops innovative smear device
This article was originally published in Clinica
Executive Summary
Ampersand Medical and AccuMed International have settled their outstanding legal disputes and revised a patent and technology deal to allow Ampersand to develop point-of-care screening for cervical, ovarian and other cancers.